Glenmark Pharmaceuticals consolidated net profit declines 8.43% in the September 2020 quarter
Sales rise 5.22% to Rs 2908.12 crore
Net profit of Glenmark Pharmaceuticals declined 8.43% to Rs 233.99 crore in the quarter ended September 2020 as against Rs 255.54 crore during the previous quarter ended September 2019. Sales rose 5.22% to Rs 2908.12 crore in the quarter ended September 2020 as against Rs 2763.73 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales2908.122763.73 5 OPM %19.0116.30 -PBDT440.30441.46 0 PBT336.24347.30 -3 NP233.99255.54 -8Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 07 2020 | 8:00 AM IST